Investigators analyzed biopsy histology from a subset of patients with lupus nephritis treated with obinutuzumab vs placebo in the phase 3 REGENCY trial ...
DENVER -- Patients with advanced kidney cancer treated with immune checkpoint inhibitors (ICIs) lived longer if they consumed ...
NPM1 mutations, one of the most common genetic drivers of AML, are now actionable for patients – – Acute unmet need in R/R ...
Your skin acts as a vital health indicator, with changes like butterfly rashes, velvet plaques, or tripe palms signaling ...
Scott Tykodi, associate professor at the UW and Fred Hutch campus, an oncologist, and specialist in treating kidney cancer ...
Oct 28 (Reuters) - Merck (MRK.N), opens new tab and Eisai's (4523.T), opens new tab experimental combination treatment helped extend the time certain patients with advanced kidney cell cancer lived ...
We'd always prioritized living fully — traveling, building traditions, and making memories. It was a sobering reminder that even if you don't put your life on hold, time is never guaranteed. When my ...
(Beyond Pesticides, October 1, 2025) A novel study in Scientific Reports combines computational analyses with toxicological data to identify pathways affected by exposure to the weed killer glyphosate ...
Kidney cancer is on the verge of becoming a far larger health problem than it currently is, with cases expected to nearly double by 2050 worldwide. That’s the bleak conclusion in a sweeping survey led ...
Modifiable risk factors including obesity, diabetes, hypertension, smoking and a lack of exercise will contribute significantly to the doubling of kidney cancer cases around the world by 2050, ...
Modifiable risk factors such as obesity, smoking, lack of exercise, diabetes and hypertension are projected to be one of the main drivers of a steep rise in kidney cancer cases, doubling the amount ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback